Accuretic (quinapril HCl/hydrochlorothiazide) Tablets, 10 mg/12.5 mg*, 90 Tablets bottles, Rx Onl...

FDA Recall #D-0754-2022 — Class II — March 21, 2022

Recall #D-0754-2022 Date: March 21, 2022 Classification: Class II Status: Terminated

Product Description

Accuretic (quinapril HCl/hydrochlorothiazide) Tablets, 10 mg/12.5 mg*, 90 Tablets bottles, Rx Only, Distributed by: Parke-Davis, Division of Pfizer Inc, NY, NY 10017, Made in Germany, NDC 0071-3112-23.

Reason for Recall

CGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity above the acceptable daily intake limit.

Recalling Firm

Pfizer Inc. — New York, NY

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

53 bottles

Distribution

Nationwide

Code Information

Lot FG5379; Exp. 08/2024

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated